pulmoПульмонологияPULMONOLOGIYA0869-01892541-9617Scientific and Practical Journal “PULMONOLOGIYA” LLC10.18093/0869-0189-2011-0-3-53-58pulmo-330Research ArticleОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯORIGINAL STUDIESКозловР. С.KozlovR. S.

д. м. н., директор 

214019, г. Смоленск, ул. Кирова, 46а. Тел.: (4812) 45-06-12.

roman@antibiotic.ruСиваяО. В.SivayaO. V.

к. м. н., научный сотрудник 

214019, г. Смоленск, ул. Кирова, 46а. Тел.: (4812) 61-13-01.

oksana@antibiotic.ruШевелевА. Н.ShevelevA. N.

к. м. н., старший научный сотрудник 

214019, г. Смоленск, ул. Кирова, 46а. Тел.: (4812) 61-13-01.

shevelev@antibiotic.ruНИИ антимикробной химиотерапии ГОУ ВПО "Смоленская государственная медицинская академия" Минздравсоцразвития РФRussian Federation201128062011035358Copyright © Козлов Р.С., Сивая О.В., Шевелев А.Н., 20112011Козлов Р.С., Сивая О.В., Шевелев А.Н.Kozlov R.S., Sivaya O.V., Shevelev A.N.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.pulmonology.ru/pulm/article/view/330ReferencesBartlett J.С., Mundy L.M., Community-acquired pneumonia. N. Engl. J. Med. 1995; 333: 1618–1624.Bartlett J.С., Mundy L.M., Community-acquired pneumonia. N. Engl. J. Med. 1995; 333: 1618–1624.Heffelfinger J.D., Dowell S.F., Jorgensen J.H. et. al. Managment of community-acquired pneumoniae in the era of pneumococcal resistance: A report from the Drug-Resistance Streptococcus Pneumoniae Therapeutic Working Group. Arch. Intern. Med. 2000; 160: 1399–1408.Heffelfinger J.D., Dowell S.F., Jorgensen J.H. et. al. Managment of community-acquired pneumoniae in the era of pneumococcal resistance: A report from the Drug-Resistance Streptococcus Pneumoniae Therapeutic Working Group. Arch. Intern. Med. 2000; 160: 1399–1408.Gooch III W.M., Golanty S.A. A review of treatment guidelines in an era of drug-resistant pneumococcal pathogens: a review of otitis media guidelines. Laguna Niguel, CA: The Institute of Medical Studies; 2000.Gooch III W.M., Golanty S.A. A review of treatment guidelines in an era of drug-resistant pneumococcal pathogens: a review of otitis media guidelines. Laguna Niguel, CA: The Institute of Medical Studies; 2000.CLSI. Performance standards for antimicrobial susceptibility testing; Twentieth informational supplement. CLSI document M100-S20. Wayne, PA: Clinical and Laboratory Standаrds Institute; 2010. 88–91.CLSI. Performance standards for antimicrobial susceptibility testing; Twentieth informational supplement. CLSI document M100-S20. Wayne, PA: Clinical and Laboratory Standаrds Institute; 2010. 88–91.European Committee on Antimicrobial Susceptibility Testing. Breakpoints tables for interpretation of MICs and zone diameters. Version 1.3. January 5, 2011. Http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST-files/Disk-test-documents/EUCAST-break5points-v1.3-pdf.pdfEuropean Committee on Antimicrobial Susceptibility Testing. Breakpoints tables for interpretation of MICs and zone diameters. Version 1.3. January 5, 2011. Http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST-files/Disk-test-documents/EUCAST-break5points-v1.3-pdf.pdfKarlowsky J.A., Jones M.E., Draghi D.C. et al. In vitro susceptibility of recent clinical isolates of pneumococci to the investigational cephalosporin cefditoren. Diagn. Microbiol. Infect. Dis. 2002; 42 (1): 59–64.Karlowsky J.A., Jones M.E., Draghi D.C. et al. In vitro susceptibility of recent clinical isolates of pneumococci to the investigational cephalosporin cefditoren. Diagn. Microbiol. Infect. Dis. 2002; 42 (1): 59–64.Statement 2003 CA-SFM. Zone sizes and MIC breakpoints for non-fastidious organisms. Clin. Microbiol. Infect. 2003; 2: S46–S48.Statement 2003 CA-SFM. Zone sizes and MIC breakpoints for non-fastidious organisms. Clin. Microbiol. Infect. 2003; 2: S46–S48.Jenkins S.G., Brown S.D., Farrell D.J. Trends in antibacterial resistance among Streaptococcus pneumoniae isolated in the USA: update from Protekt US Years 1–4. Ann. Clin. Microbiol. Antimicrob. 2008; 7 (1): 1.Jenkins S.G., Brown S.D., Farrell D.J. Trends in antibacterial resistance among Streaptococcus pneumoniae isolated in the USA: update from Protekt US Years 1–4. Ann. Clin. Microbiol. Antimicrob. 2008; 7 (1): 1.Perez Trallero E., Martin Yerrero J.E., Mazon A. et al. Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996–1997 to 2006–2007). Antimicrob Agents Chemother 2008; 54 (7): 2953–2959.Perez Trallero E., Martin Yerrero J.E., Mazon A. et al. Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996–1997 to 2006–2007). Antimicrob Agents Chemother 2008; 54 (7): 2953–2959.Inoue M., Farrell D.J., Kaneko K. et al. Antimicrobial susceptibility of respiratory tract pathogens in Japan during PROTEKT years 1–5 (1999–2004). Microb. Drug Resist. 2008; 14 (72): 109–117.Inoue M., Farrell D.J., Kaneko K. et al. Antimicrobial susceptibility of respiratory tract pathogens in Japan during PROTEKT years 1–5 (1999–2004). Microb. Drug Resist. 2008; 14 (72): 109–117.

The authors declare that there are no conflicts of interest present.